Rocket One Inc. Short-term Lease, Cost
Rocket One Inc. (RKTO) reported Short-term Lease, Cost of $5.88 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2026-08-14
- Rocket One Inc. short-term lease, cost for the quarter ending 2026-06-30 was $5.88K, a 2.89% increase year-over-year.
- Rocket One Inc. short-term lease, cost for the quarter ending 2026-03-31 was $6.21K, a 9.72% increase year-over-year.
- Rocket One Inc. short-term lease, cost for the quarter ending 2025-12-31 was $5.71K, a 23.34% decline year-over-year.
- Rocket One Inc. short-term lease, cost for the quarter ending 2025-09-30 was $7.62K, a 90.98% increase year-over-year.
- Rocket One Inc. short-term lease, cost for fiscal 2025 was $24.71K, a 29.14% increase from fiscal 2024.
- Rocket One Inc. short-term lease, cost for fiscal 2024 was $19.14K, a 42.63% decline from fiscal 2023.
- Rocket One Inc. short-term lease, cost for fiscal 2023 was $33.35K, a 50.10% decline from fiscal 2022.
- Rocket One Inc. short-term lease, cost for fiscal 2022 was $66.83K.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.88K 10-Q · filed 2026-08-14 | $12.09K 10-Q · filed 2026-08-14 | $17.80K derived: sum of 3 quarters · filed 2026-08-14 | $25.43K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $6.21K 10-Q · filed 2026-05-15 | $11.93K derived: sum of 2 quarters · filed 2026-05-15 | $19.55K derived: sum of 3 quarters · filed 2026-05-15 | $25.26K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $5.71K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $13.34K derived: sum of 2 quarters · filed 2026-03-27 | $19.05K derived: sum of 3 quarters · filed 2026-08-14 | $24.71K 10-K · filed 2026-03-27 |
| 2025-09-30 | $7.62K 10-Q · filed 2025-11-12 | $13.34K derived: sum of 2 quarters · filed 2026-08-14 | $19.00K 10-Q · filed 2025-11-12 | $26.45K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $5.71K 10-Q · filed 2026-08-14 | $11.38K 10-Q · filed 2026-08-14 | $18.83K derived: sum of 3 quarters · filed 2026-08-14 | $22.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $5.66K 10-Q · filed 2026-05-15 | $13.12K derived: sum of 2 quarters · filed 2026-05-15 | $17.11K derived: sum of 3 quarters · filed 2026-05-15 | $22.95K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $7.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $11.45K derived: sum of 2 quarters · filed 2026-03-27 | $17.29K derived: sum of 3 quarters · filed 2026-03-27 | $19.14K 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.99K 10-Q · filed 2025-11-12 | $9.83K derived: sum of 2 quarters · filed 2025-11-12 | $11.68K 10-Q · filed 2025-11-12 | $18.07K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.84K 10-Q · filed 2025-08-12 | $10.49K 10-Q · filed 2025-08-12 | $14.07K derived: sum of 3 quarters · filed 2025-08-12 | $20.83K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $4.65K 10-Q · filed 2025-05-12 | $8.23K derived: sum of 2 quarters · filed 2025-05-12 | $14.99K derived: sum of 3 quarters · filed 2025-05-12 | $22.88K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $3.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $10.33K derived: sum of 2 quarters · filed 2025-03-28 | $18.23K derived: sum of 3 quarters · filed 2025-03-28 | $33.35K 10-K · filed 2025-03-28 |
| 2023-09-30 | $6.75K 10-Q · filed 2024-11-12 | $14.65K derived: sum of 2 quarters · filed 2024-11-12 | $29.77K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $7.90K 10-Q · filed 2024-08-09 | $23.02K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $15.12K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $66.83K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |